Login / Signup

Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor.

Hemant SuryavanshiRaju D ChaudhariVishakha PatilSwapan MajumdarSudhan DebnathGoutam Biswas
Published in: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2022)
This study shows that some vortioxetine derivatives can be developed into promising drugs for COVID-19 treatment.
Keyphrases
  • sars cov
  • major depressive disorder
  • respiratory syndrome coronavirus
  • small molecule
  • drug induced
  • protein protein